Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Disruptive Innovation in Dialysis and Medical Device Manufacturing

Disruptors come in many flavors and innovate countless industries. Healthcare is one space that welcomes technology disruption, where advancements in medical devices can improve the lives of many. Outset Medical is one such medical device manufacturer seeking to transform the dialysis experience. Marc Nash, VP of Manufacturing at Outset Medical, joined DisruptED’s Ron Stefanski…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from DisruptED on MarketScale.

Share

Disruptors come in many flavors and innovate countless industries. Healthcare is one space that welcomes technology disruption, where advancements in medical devices can improve the lives of many. Outset Medical is one such medical device manufacturer seeking to transform the dialysis experience.

Marc Nash, VP of Manufacturing at Outset Medical, joined DisruptED’s Ron Stefanski to share his company’s exciting work to improve the dialysis process and experience. A dialysis patient must endure a cumbersome lifelong process that creates a burden for them and their family, not to mention the physical toll it carries on the body.

“We wanted to see how we could give patients back their life,” Nash said. “How could they take more control over what they could do? So, we created a product called Tablo, and we’re now in the home market.”

Making dialysis available in a patient’s home is a critical first step in that journey to give patients their freedom back. With a typical dialysis treatment taking five hours and up to three times a week, not traveling to a healthcare facility to get treatment can be a game-changer.

“Imagine if you wanted to do dialysis at 7 p.m. to 10 p.m. or 11 p.m., most clinics are not going to be open during these times,” Nash said. “Where if you’re in the comfort of your house, you can go to work, take care of the kids, and then go about your dialysis.”

Nash said it comes down to the people within Outset Medical to make strides in dialysis.

“When I hire within my organization, I’m looking for attitude. I want to see the people that have grit and determination. Most people are not going to come to my organization knowing dialysis; they’re going to come from either the Medtech space, aerospace, they’re going to come from automotive, or tech, and I’m going to have to teach them dialysis. That’s the easy part. What’s hard to teach is grit.”

DisruptED

Part of this channel

DisruptED

Education, workforce, and manufacturing futures with Ron J. Stefanski.

Visit the channel

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Leading with Purpose: Dr. David Foster on Faith, Healthcare Leadership, and Physician Collaboration

Dr. David Foster discusses the importance of faith in healthcare leadership and the role of physician collaboration. The conversation emphasizes how values-driven leadership can positively impact patient care. The dialogue also explores the significance of integrating personal beliefs in professional settings.

  • 01Values-driven leadership can significantly enhance patient care.
  • 02Integrating personal beliefs in professional settings can benefit healthcare leadership.
  • 03Collaboration among physicians is crucial for effective healthcare leadership.

Aug 4, 2026

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health venture funding reached $7.4B in the first half of 2026, with significant investments in AI agent platforms and chronic care tools. Mega-deals of over $100 million were a key driver of the funding surge.

  • 01Digital health VC funding hit $7.4 billion in the first half of 2026.
  • 02Mega-deals in AI agent platforms and chronic care tools exceeded $100 million.
  • 03AI, chronic care, and workforce tools dominate digital health investments.

Aug 4, 2026

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Three significant transactions occurred in the pharmaceutical and medtech sectors on August 3, highlighting a split M&A market. While mid-market buyouts such as KKR's acquisition of Integer Holdings and Curium's purchase of Lantheus proceeded, larger megamergers like AstraZeneca's faced obstacles. This suggests a trend towards restructuring within the industry.

  • 01KKR acquired Integer Holdings for $5.7 billion.
  • 02Curium purchased Lantheus in an $8 billion deal.
  • 03AstraZeneca's megamerger attempt was blocked.

Aug 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512